Results 221 to 230 of about 8,062,145 (231)

Drug Repositioning for Orphan Diseases.

Briefings in Bioinformatics, 2011
Anil G. Jegga, Minlu Zhang, Lun Yang
exaly  

Orphan Drugs and Their Impact on Pharmaceutical Development

Trends in Pharmacological Sciences, 2018
Helgi B Schiöth, Misty M Attwood, Mathias Rask-Andersen   +2 more
exaly  

The US Orphan Drug Act: Rare Disease Research Stimulator or Commercial Opportunity?

Health Policy, 2010
Youwen Zhou, Olivier Wellman-Labadie
exaly  

Rare Diseases and Orphan Drugs

Nature Reviews Drug Discovery, 2012
Irena Melnikova
exaly  

Issues Surrounding Orphan Disease and Orphan Drug Policies in Europe

Applied Health Economics and Health Policy, 2010
Lut Mergaert, Steven Simoens, Irina Cleemput   +2 more
exaly  

Post-Authorisation Assessment of Orphan Drugs

Lancet, The, 2015
Carla Hollak, Marieke Biegstraaten
exaly  

Emergence of Orphan Drugs in the United States: A Quantitative Assessment of the First 25 Years

Nature Reviews Drug Discovery, 2010
exaly  

Are Orphan Drug Companies the Pick of the Pharmaceutical Industry?

Nature Reviews Drug Discovery, 2014
Thomas Morel, Steven Simoens
exaly  

Rare Diseases, Orphan Drugs and Their Regulation: Questions and Misconceptions

Nature Reviews Drug Discovery, 2010
exaly  

Pricing of Orphan Drugs

Lancet, The, 2009
S Richmond, J V Leonard
exaly